4.6 Article

Gut microbiome alterations in preclinical Alzheimer's disease

期刊

PLOS ONE
卷 17, 期 11, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0278276

关键词

-

资金

  1. Ministry of Science and ICT, Republic of Korea [NRF-2014M3C7A1046042]
  2. Ministry of Health & Welfare, Republic of Korea [HI18C0630, HI19C0149]
  3. Seoul National University Hospital, Republic of Korea [3020200030]
  4. National Institute on Aging, United States of America [U01AG072177]

向作者/读者索取更多资源

This study found specific alterations of gut bacterial taxa associated with preclinical Alzheimer's disease, suggesting that these changes may occur before cognitive decline.
Background Although some human studies have reported gut microbiome changes in individuals with Alzheimer's disease (AD) dementia or mild cognitive impairment (MCI), gut microbiome alterations in preclinical AD, i.e., cerebral amyloidosis without cognitive impairment, is largely unknown. Objective We aimed to identify gut microbial alterations associated with preclinical AD by comparing cognitively normal (CN) older adults with cerebral A beta deposition (A beta+ CN) and those without cerebral A beta deposition (A beta- CN). Methods Seventy-eight CN older participants (18 A beta+ CN and 60 A beta- CN) were included, and all participants underwent clinical assessment and Pittsburg compound B-positron emission tomography. The V3-V4 region of the 16S rRNA gene of genomic DNA extracted from feces was amplified and sequenced to establish the microbial community. Results Generalized linear model analysis revealed that the genera Megamonas (B = 3.399, q<0.001), Serratia (B = 3.044, q = 0.005), Leptotrichia (B = 5.862, q = 0.024) and Clostridium (family Clostridiaceae) (B = 0.788, q = 0.034) were more abundant in the A beta+ CN group than the A beta- CN group. In contrast, genera CF231 (B = -3.237, q< 0.001), Victivallis (B = -3.447, q = 0.004) Enterococcus (B = -2.044, q = 0.042), Mitsuokella (B = -2.119, q = 0.042) and Clostridium (family Erysipelotrichaceae) (B = -2.222, q = 0.043) were decreased in A beta+ CN compared to A beta- CN. Notably, the classification model including the differently abundant genera could effectively distinguish A beta+ CN from A beta- CN (AUC = 0.823). Conclusion Our findings suggest that specific alterations of gut bacterial taxa are related to preclinical AD, which means these changes may precede cognitive decline. Therefore, examining changes in the microbiome may be helpful in preclinical AD screening.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据